Blood Cancer: Coronavirus | Department of Health and Social Care | Written Answers NHS England and NHS Improvement want to ensure innovations can be adapted into a sustainable model into the future, to better meets patie
Diabetes: Coronavirus | Department of Health and Social Care | Written Answers Throughout the COVID-19 pandemic diabetes care has remained a priority, and general practitioners (GPs) have supported patients with long
Haemophilia | Department of Health and Social Care | Written Answers This information is not held by NHS England but is held on the United Kingdom Haemophilia Centre Doctors' Organisation’s (UKHCDO) Nationa
Cancer: Drugs | Department of Health and Social Care | Written Answers Between April 2019 to March 2020, the expenditure for the Cancer Drugs Fund was £317 million.
Rare Diseases | Department of Health and Social Care | Written Answers There are no plans to update the National Institute for Health and Care Excellence (Constitution and Functions) and the Health and Social
Medical Treatments: Innovation | Department of Health and Social Care | Written Answers Proposals for the Innovative Medicines Fund (IMF) are in development and will take full account of stakeholder views to ensure best use o
Epilepsy: Cannabis | Department of Health and Social Care | Written Answers I refer the Rt. hon. Member to the answer I gave on 15 May 2020 to Question 43850. No assessment has been made.
Hormone Replacement Therapy | Department of Health and Social Care | Written Answers Our priority is to ensure that patients continue to have access to medicines and medical products they need.
Coronavirus: Sweden | Department of Health and Social Care | Written Answers The Secretary of State for Health and Social Care has many discussions with his international counterparts, but no official meetings have
Cannabis: Medical Treatments | Department of Health and Social Care | Written Answers No assessment has been made.